TELA
Income statement / Annual
Last year (2023), TELA Bio, Inc.'s total revenue was $58.45 M,
an increase of 41.13% from the previous year.
In 2023, TELA Bio, Inc.'s net income was -$46.66 M.
See TELA Bio, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
| Operating Revenue |
$58.45 M
|
$41.42 M
|
$29.46 M
|
$18.21 M
|
$15.45 M
|
$8.27 M
|
$4.25 M
|
| Cost of Revenue |
$18.34 M |
$14.37 M |
$10.65 M |
$6.98 M |
$6.17 M |
$5.33 M |
$1.71 M |
| Gross Profit |
$40.11 M |
$27.04 M |
$18.81 M |
$11.23 M |
$9.27 M |
$2.94 M |
$2.53 M |
| Gross Profit Ratio |
0.69 |
0.65 |
0.64 |
0.62 |
0.6 |
0.36 |
0.6 |
| Research and Development
Expenses |
$9.62 M
|
$8.94 M
|
$6.74 M
|
$4.26 M
|
$4.15 M
|
$4.34 M
|
$5.79 M
|
| General & Administrative
Expenses |
$14.89 M
|
$13.86 M
|
$12.46 M
|
$10.14 M
|
$6.22 M
|
$4.90 M
|
$4.96 M
|
| Selling & Marketing
Expenses |
$59.68 M
|
$43.25 M
|
$29.06 M
|
$22.11 M
|
$18.06 M
|
$13.65 M
|
$8.71 M
|
| Selling, General &
Administrative Expenses |
$74.57 M
|
$57.11 M
|
$41.52 M
|
$32.25 M
|
$24.28 M
|
$18.55 M
|
$13.67 M
|
| Other Expenses |
$0.00 |
-$10,000.00 |
-$228,000.00 |
$45,000.00 |
$351,000.00 |
$70,000.00 |
$94,000.00 |
| Operating Expenses |
$84.19 M |
$66.05 M |
$48.26 M |
$36.51 M |
$28.43 M |
$22.88 M |
$19.46 M |
| Cost And Expenses |
$102.53 M |
$80.43 M |
$58.91 M |
$43.49 M |
$34.61 M |
$28.22 M |
$21.17 M |
| Interest Income |
$0.00 |
$4.05 M |
$3.60 M |
$3.56 M |
$3.61 M |
$0.00 |
$0.00 |
| Interest Expense |
$5.22 M |
$4.05 M |
$3.60 M |
$3.56 M |
$3.61 M |
$1.80 M |
$4.56 M |
| Depreciation &
Amortization |
$808,000.00
|
$1.19 M
|
$535,000.00
|
$525,000.00
|
$582,000.00
|
$1.25 M
|
$761,000.00
|
| EBITDA |
-$40.63 M
|
-$39.06 M
|
-$29.14 M
|
-$24.71 M
|
-$18.23 M
|
-$18.04 M
|
-$16.02 M
|
| EBITDA Ratio |
-0.7 |
-0.94 |
-1.01 |
-1.39 |
-1.22 |
-2.25 |
-3.79 |
| Operating Income Ratio
|
-0.75
|
-0.94
|
-1
|
-1.39
|
-1.24
|
-2.15
|
-3.99
|
| Total Other
Income/Expenses Net |
-$2.59 M
|
-$5.29 M
|
-$3.83 M
|
-$3.52 M
|
-$3.26 M
|
-$3.31 M
|
-$4.41 M
|
| Income Before Tax |
-$46.66 M |
-$44.30 M |
-$33.28 M |
-$28.79 M |
-$22.43 M |
-$21.09 M |
-$21.33 M |
| Income Before Tax Ratio
|
-0.8
|
-1.07
|
-1.13
|
-1.58
|
-1.45
|
-2.55
|
-5.03
|
| Income Tax Expense |
$0.00 |
$41,000.00 |
$2.83 M |
$3.08 M |
$3.38 M |
-$1.51 M |
$4.65 M |
| Net Income |
-$46.66 M |
-$44.34 M |
-$36.11 M |
-$31.88 M |
-$25.80 M |
-$21.09 M |
-$21.33 M |
| Net Income Ratio |
-0.8 |
-1.07 |
-1.23 |
-1.75 |
-1.67 |
-2.55 |
-5.03 |
| EPS |
-2.04 |
-2.73 |
-2.49 |
-2.46 |
-2.26 |
-3.25 |
-3.29 |
| EPS Diluted |
-2.04 |
-2.73 |
-2.49 |
-2.46 |
-2.26 |
-3.25 |
-3.29 |
| Weighted Average Shares
Out |
$22.87 M
|
$16.27 M
|
$14.47 M
|
$12.93 M
|
$11.41 M
|
$6.49 M
|
$6.49 M
|
| Weighted Average Shares
Out Diluted |
$22.87 M
|
$16.27 M
|
$14.47 M
|
$12.93 M
|
$11.41 M
|
$6.49 M
|
$6.49 M
|
| Link |
|
|
|
|
|
|
|
